- Home
- MTLS vs FDMT Comparison
MTLS vs FDMT Comparison
Compare MTLS & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- FDMT
- Stock Information
- Founded
- MTLS 1990
- FDMT 2013
- Country
- MTLS Belgium
- FDMT United States
- Employees
- MTLS N/A
- FDMT N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- MTLS Technology
- FDMT Health Care
- Exchange
- MTLS Nasdaq
- FDMT Nasdaq
- Market Cap
- MTLS 297.1M
- FDMT 268.6M
- IPO Year
- MTLS 2014
- FDMT 2020
- Fundamental
- Price
- MTLS $5.21
- FDMT $3.88
- Analyst Decision
- MTLS Buy
- FDMT Buy
- Analyst Count
- MTLS 1
- FDMT 10
- Target Price
- MTLS $9.50
- FDMT $35.00
- AVG Volume (30 Days)
- MTLS 509.5K
- FDMT 659.3K
- Earning Date
- MTLS 04-24-2025
- FDMT 05-08-2025
- Dividend Yield
- MTLS N/A
- FDMT N/A
- EPS Growth
- MTLS 106.79
- FDMT N/A
- EPS
- MTLS 0.24
- FDMT N/A
- Revenue
- MTLS $276,182,835.00
- FDMT $37,000.00
- Revenue This Year
- MTLS $6.55
- FDMT $11,029.73
- Revenue Next Year
- MTLS $9.21
- FDMT $44.15
- P/E Ratio
- MTLS $22.23
- FDMT N/A
- Revenue Growth
- MTLS 4.15
- FDMT N/A
- 52 Week Low
- MTLS $4.70
- FDMT $3.73
- 52 Week High
- MTLS $9.69
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- MTLS 33.32
- FDMT 42.10
- Support Level
- MTLS $4.87
- FDMT $3.73
- Resistance Level
- MTLS $5.35
- FDMT $4.44
- Average True Range (ATR)
- MTLS 0.18
- FDMT 0.36
- MACD
- MTLS 0.07
- FDMT 0.03
- Stochastic Oscillator
- MTLS 52.59
- FDMT 39.86
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, Poland, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.